| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatase binding | 2.00e-04 | 264 | 187 | 10 | GO:0019902 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 ENPP1 PLA2G4D TENM2 IQGAP1 DUOX1 PLCB1 PLCD1 NOTCH1 PADI1 EFCAB6 DSG2 EFCAB2 PCDHB18P HMCN1 UNC13C CDH6 CDH10 | 2.47e-04 | 749 | 187 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | histone H3K9 acetyltransferase activity | 2.60e-04 | 3 | 187 | 2 | GO:0043992 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.73e-04 | 14 | 187 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | GDPD1 PALD1 RNGTT ENPP1 NT5DC1 CILP2 PTPRO PLCB1 PLCD1 GPLD1 DUSP14 CTDSPL | 2.95e-04 | 386 | 187 | 12 | GO:0042578 |
| GeneOntologyMolecularFunction | lipid binding | EPHX1 ACADM CYTH3 CYTH2 PLA2G4D WASHC2A IQGAP1 DENND1B PGRMC2 PLCB1 PLEKHA5 PLCD1 VCP WASHC2C SMURF1 PARD3B PPARG CD81 UNC13C LTF MARK2 | 3.94e-04 | 988 | 187 | 21 | GO:0008289 |
| GeneOntologyBiologicalProcess | response to interleukin-15 | 4.14e-08 | 12 | 185 | 5 | GO:0070672 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.26e-06 | 10 | 185 | 4 | GO:0060397 | |
| GeneOntologyBiologicalProcess | interleukin-15-mediated signaling pathway | 1.97e-06 | 11 | 185 | 4 | GO:0035723 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-15 | 1.97e-06 | 11 | 185 | 4 | GO:0071350 | |
| GeneOntologyBiologicalProcess | response to interleukin-2 | 1.97e-06 | 11 | 185 | 4 | GO:0070669 | |
| GeneOntologyBiologicalProcess | interleukin-9-mediated signaling pathway | 2.42e-05 | 7 | 185 | 3 | GO:0038113 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-9 | 2.42e-05 | 7 | 185 | 3 | GO:0071355 | |
| GeneOntologyBiologicalProcess | response to interleukin-9 | 3.85e-05 | 8 | 185 | 3 | GO:0071104 | |
| GeneOntologyBiologicalProcess | T cell differentiation | ENPP1 IRF4 KAT2A STAT3 STAT5A STAT5B FANCD2 JAK3 SYK THEMIS SH3RF1 CD3E SMARCA2 | 4.33e-05 | 382 | 185 | 13 | GO:0030217 |
| GeneOntologyBiologicalProcess | lipid storage | 4.53e-05 | 105 | 185 | 7 | GO:0019915 | |
| GeneOntologyBiologicalProcess | interleukin-2-mediated signaling pathway | 5.73e-05 | 9 | 185 | 3 | GO:0038110 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-2 | 5.73e-05 | 9 | 185 | 3 | GO:0071352 | |
| GeneOntologyBiologicalProcess | positive regulation of small molecule metabolic process | 6.11e-05 | 192 | 185 | 9 | GO:0062013 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 8.00e-05 | 2 | 185 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 8.00e-05 | 2 | 185 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway | 8.03e-05 | 26 | 185 | 4 | GO:0060396 | |
| GeneOntologyBiologicalProcess | proline metabolic process | 8.13e-05 | 10 | 185 | 3 | GO:0006560 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | ENPP1 STAT3 STAT5A STAT5B JAK3 KAT2B SCNN1A PLCB1 PLCD1 GPLD1 SRSF6 CAMK2A PPARG DENND4C CRY2 | 9.14e-05 | 530 | 185 | 15 | GO:0043434 |
| GeneOntologyBiologicalProcess | cellular response to growth hormone stimulus | 9.36e-05 | 27 | 185 | 4 | GO:0071378 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | TBC1D19 AHI1 ARHGAP24 CYTH2 TBC1D2 KAT2A TENM2 IQGAP1 MET KAT2B PTPRO P3H1 LRRC7 TBX6 FLNA FIGNL2 SMURF1 IL1RAPL1 DYNC2LI1 MARK2 | 1.01e-04 | 863 | 185 | 20 | GO:0031344 |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.02e-04 | 52 | 185 | 5 | GO:0042789 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell differentiation | 1.47e-04 | 12 | 185 | 3 | GO:0045588 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 1.58e-04 | 57 | 185 | 5 | GO:0009299 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | ENPP1 STAT3 STAT5A STAT5B JAK3 KAT2B SCNN1A PLCB1 GPLD1 CAMK2A PPARG DENND4C | 1.76e-04 | 381 | 185 | 12 | GO:0071375 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | ENPP1 STAT3 STAT5A STAT5B JAK3 DUOX1 KAT2B XRN1 SCNN1A SYK PLCB1 PLCD1 C5AR1 MYRF NOTCH1 VCP GPLD1 FLNA SRSF6 CAMK2A TRIM41 PPARG DENND4C CRY2 CD81 | 1.84e-04 | 1272 | 185 | 25 | GO:1901698 |
| GeneOntologyBiologicalProcess | gamma-delta T cell activation | 2.09e-04 | 33 | 185 | 4 | GO:0046629 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.11e-04 | 226 | 185 | 9 | GO:0045580 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | ENPP1 IRF4 KAT2A STAT3 STAT5A STAT5B FANCD2 JAK3 SYK PLCB1 THEMIS SH3RF1 IRF8 PPARG CD3E SMARCA2 | 2.21e-04 | 640 | 185 | 16 | GO:1903131 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | TBC1D19 AHI1 ARHGAP24 CYTH2 TBC1D2 TENM2 IQGAP1 MET KAT2B PTPRO P3H1 LRRC7 TBX6 FLNA FIGNL2 SMURF1 IL1RAPL1 DYNC2LI1 MARK2 | 2.25e-04 | 846 | 185 | 19 | GO:0120035 |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 2.39e-04 | 3 | 185 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 2.39e-04 | 3 | 185 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 2.39e-04 | 3 | 185 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 2.39e-04 | 3 | 185 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | positive regulation of gamma-delta T cell activation | 2.40e-04 | 14 | 185 | 3 | GO:0046645 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 2.48e-04 | 231 | 185 | 9 | GO:0006109 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | ENPP1 IRF4 KAT2A STAT3 STAT5A STAT5B FANCD2 JAK3 SYK PLCB1 THEMIS SH3RF1 IRF8 PPARG CD3E SMARCA2 CD81 LTF | 2.74e-04 | 789 | 185 | 18 | GO:0002521 |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell differentiation | 2.98e-04 | 15 | 185 | 3 | GO:0045586 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | ENPP1 STAT3 STAT5A STAT5B JAK3 KAT2B PGRMC2 DDX54 SCNN1A PLCB1 NOTCH1 GPLD1 VPS18 CAMK2A PPARG DENND4C CRY2 | 3.07e-04 | 727 | 185 | 17 | GO:0032870 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | BRINP3 CDK11A ACVR1 STAT5A STAT5B IQGAP1 FANCD2 MET PLCB1 UBE2C MAD2L1BP CCNH SMARCA2 SLFN11 CTDSPL | 3.14e-04 | 594 | 185 | 15 | GO:0007346 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | ARHGAP24 TBC1D2 CMYA5 STAT3 IQGAP1 MET DENND1B SYK ARHGAP29 VCP GPLD1 VTN SH3RF1 CAMK2A PPP6R1 PPARG FETUB CRY2 LTF | 3.58e-04 | 878 | 185 | 19 | GO:0051336 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | ENPP1 IRF4 KAT2A STAT3 STAT5A STAT5B FANCD2 JAK3 SYK THEMIS SH3RF1 IRF8 CD3E SMARCA2 | 3.63e-04 | 537 | 185 | 14 | GO:0030098 |
| GeneOntologyBiologicalProcess | cellular catabolic process | GDPD1 ACADM DAO PLA2G4D STAT3 PHKA1 MET DUOX1 KAT2B PLCB1 ATP6V0D2 HSD17B4 FOXK1 VCP GPLD1 VPS18 NAALAD2 IRF8 SMURF1 RNF213 OAT THOP1 ALDH4A1 MARK2 | 3.64e-04 | 1253 | 185 | 24 | GO:0044248 |
| GeneOntologyBiologicalProcess | T cell selection | 3.88e-04 | 69 | 185 | 5 | GO:0045058 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 4.29e-04 | 249 | 185 | 9 | GO:0010976 | |
| GeneOntologyBiologicalProcess | regulation of gamma-delta T cell activation | 4.40e-04 | 17 | 185 | 3 | GO:0046643 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 4.40e-04 | 17 | 185 | 3 | GO:0016081 | |
| GeneOntologyBiologicalProcess | response to hormone | ENPP1 STAT3 STAT5A STAT5B JAK3 KAT2B PGRMC2 DDX54 SCNN1A PLCB1 PLCD1 NOTCH1 GPLD1 VPS18 SH3RF1 SRSF6 DSG2 CAMK2A PPARG DENND4C CRY2 | 4.49e-04 | 1042 | 185 | 21 | GO:0009725 |
| GeneOntologyBiologicalProcess | proline catabolic process | 4.74e-04 | 4 | 185 | 2 | GO:0006562 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 4.74e-04 | 4 | 185 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | EPHX1 CYP7A1 ENPP1 KAT2A STAT3 STAT5A STAT5B DUOX1 PGRMC2 DDX54 XRN1 SCNN1A PLCB1 MYRF GPLD1 FLNA VPS18 SH3RF1 DSG2 PPARG CRY2 | 4.84e-04 | 1048 | 185 | 21 | GO:0014070 |
| GeneOntologyBiologicalProcess | response to growth hormone | 4.90e-04 | 41 | 185 | 4 | GO:0060416 | |
| GeneOntologyBiologicalProcess | response to lipid | BRINP3 CYP7A1 STAT3 STAT5B MEST CACTIN PGRMC2 DDX54 XRN1 SCNN1A SYK PLCB1 NOTCH1 GPLD1 VPS18 SH3RF1 DSG2 TRIM41 IRF8 PPARG CRY2 LTF | 4.98e-04 | 1126 | 185 | 22 | GO:0033993 |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.25e-04 | 18 | 185 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-2 production | 5.37e-04 | 42 | 185 | 4 | GO:0032743 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 ACVR1 TENM2 DSG2 PCDHB18P IL1RAPL1 HMCN1 MAPK7 CDH6 CDH10 | 5.48e-04 | 313 | 185 | 10 | GO:0098742 |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 6.43e-04 | 44 | 185 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 ACVR1 TENM2 STAT5A STAT5B JAK3 SYK LRRC7 NOTCH1 FLNA DSG2 ST3GAL4 PCDHB18P IL1RAPL1 CD3E HMCN1 SMARCA2 CD81 MAPK7 CDH6 CDH10 | 6.89e-04 | 1077 | 185 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 6.89e-04 | 266 | 185 | 9 | GO:0045619 | |
| GeneOntologyCellularComponent | adherens junction | AHI1 ARHGAP24 CYTH3 CYTH2 LRRC7 NOTCH1 PARD3B HMCN1 CDH6 CDH10 | 2.42e-05 | 212 | 189 | 10 | GO:0005912 |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 AHI1 ARHGAP24 CYTH3 CYTH2 TENM2 IQGAP1 LRRC7 NOTCH1 FLNA THEMIS DSG2 PARD3B CD3E HMCN1 CDH6 CDH10 | 2.79e-05 | 591 | 189 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | glutamatergic synapse | CYTH2 TENM2 STAT3 PTPRO PGRMC2 PLCB1 PLEKHA5 LRRC7 NOTCH1 VCP SHANK1 FLNA VPS18 CAMK2A IL1RAPL1 NETO1 MARK2 RIMS2 CDH6 CDH10 | 5.36e-05 | 817 | 189 | 20 | GO:0098978 |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 AHI1 ARHGAP24 CYTH3 CYTH2 TBC1D2 TENM2 IQGAP1 LRRC7 NOTCH1 FLNA FLNC THEMIS DSG2 PARD3B CD3E HMCN1 CLCA2 CD81 CDH6 CDH10 | 2.11e-04 | 976 | 189 | 21 | GO:0070161 |
| HumanPheno | Pain | ARHGAP24 ACADM ENPP1 KIF1B DAO IRF4 ACVR1 STAT3 STAT5B PHKA1 MET PTPRO SCNN1A SYK VCP TBX6 FLNC DSG2 POLD1 TMEM43 PPARG JMJD1C CD81 ALDH4A1 | 8.69e-06 | 846 | 59 | 24 | HP:0012531 |
| MousePheno | increased anxiety-related response | DAO CMYA5 NT5DC1 SGCE LRRC7 ATP13A3 HSD17B4 VCP SHANK1 FOLH1 CAMK2A ST3GAL4 TMEM43 TPH2 CSMD1 | 2.24e-06 | 311 | 157 | 15 | MP:0001363 |
| Domain | STAT_TF_DNA-bd_sub | 3.30e-05 | 7 | 186 | 3 | IPR012345 | |
| Domain | STAT | 3.30e-05 | 7 | 186 | 3 | IPR001217 | |
| Domain | STAT_int | 3.30e-05 | 7 | 186 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 3.30e-05 | 7 | 186 | 3 | IPR013801 | |
| Domain | STAT_bind | 3.30e-05 | 7 | 186 | 3 | PF02864 | |
| Domain | STAT_int | 3.30e-05 | 7 | 186 | 3 | PF02865 | |
| Domain | - | 3.30e-05 | 7 | 186 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 3.30e-05 | 7 | 186 | 3 | PF01017 | |
| Domain | - | 3.30e-05 | 7 | 186 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 3.30e-05 | 7 | 186 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 3.30e-05 | 7 | 186 | 3 | IPR015988 | |
| Domain | - | 3.30e-05 | 7 | 186 | 3 | 2.60.40.630 | |
| Domain | STAT_TF_alpha | 5.25e-05 | 8 | 186 | 3 | IPR013800 | |
| Domain | Hist_acetylase_PCAF | 9.86e-05 | 2 | 186 | 2 | IPR016376 | |
| Domain | PCAF_N | 9.86e-05 | 2 | 186 | 2 | IPR009464 | |
| Domain | PCAF_N | 9.86e-05 | 2 | 186 | 2 | PF06466 | |
| Domain | FAM21 | 9.86e-05 | 2 | 186 | 2 | IPR027308 | |
| Domain | p53-like_TF_DNA-bd | 1.81e-04 | 53 | 186 | 5 | IPR008967 | |
| Domain | Teashirt_fam | 2.94e-04 | 3 | 186 | 2 | IPR027008 | |
| Domain | CAP-ZIP_m | 2.94e-04 | 3 | 186 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 2.94e-04 | 3 | 186 | 2 | IPR029341 | |
| Domain | PH_dom-like | ARHGAP24 CYTH3 CYTH2 KIF1B TBC1D2 JAK3 PLCB1 PLEKHA5 PLCD1 DOK1 CDC42BPG MTMR12 FRMD3 | 3.55e-04 | 426 | 186 | 13 | IPR011993 |
| Domain | PH | ARHGAP24 CYTH3 CYTH2 KIF1B TBC1D2 PLEKHA5 PLCD1 DOK1 CDC42BPG | 4.95e-04 | 229 | 186 | 9 | PF00169 |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 4.49e-08 | 5 | 139 | 4 | M48987 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.10e-06 | 9 | 139 | 4 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.10e-06 | 9 | 139 | 4 | M8066 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.10e-06 | 9 | 139 | 4 | MM1419 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.82e-06 | 10 | 139 | 4 | M27898 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 4.21e-06 | 12 | 139 | 4 | M27893 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 8.39e-06 | 14 | 139 | 4 | M27858 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.84e-05 | 6 | 139 | 3 | MM15621 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.84e-05 | 6 | 139 | 3 | MM15581 | |
| Pathway | WP_IL9_SIGNALING | 1.95e-05 | 17 | 139 | 4 | M39644 | |
| Pathway | PID_GMCSF_PATHWAY | 2.56e-05 | 36 | 139 | 5 | M22 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 3.19e-05 | 7 | 139 | 3 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 3.19e-05 | 7 | 139 | 3 | M47430 | |
| Pathway | WP_IL2_SIGNALING | 5.50e-05 | 42 | 139 | 5 | M39536 | |
| Pathway | PID_TCPTP_PATHWAY | 5.50e-05 | 42 | 139 | 5 | M91 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 5.77e-05 | 22 | 139 | 4 | M7747 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 6.91e-05 | 44 | 139 | 5 | M1012 | |
| Pathway | BIOCARTA_IL2_PATHWAY | 6.93e-05 | 23 | 139 | 4 | MM1411 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 6.93e-05 | 23 | 139 | 4 | M47904 | |
| Pathway | REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING | 9.75e-05 | 25 | 139 | 4 | M41829 | |
| Pathway | WP_IL7_SIGNALING | 9.75e-05 | 25 | 139 | 4 | M39499 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.07e-04 | 10 | 139 | 3 | MM15618 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.07e-04 | 10 | 139 | 3 | MM15535 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 1.14e-04 | 26 | 139 | 4 | M27750 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.46e-04 | 11 | 139 | 3 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.46e-04 | 11 | 139 | 3 | MM15578 | |
| Pathway | WP_IL4_SIGNALING | 1.86e-04 | 54 | 139 | 5 | M39720 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 1.93e-04 | 12 | 139 | 3 | MM1342 | |
| Pathway | PID_IL2_1PATHWAY | 2.03e-04 | 55 | 139 | 5 | M122 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 2.03e-04 | 30 | 139 | 4 | M41825 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 2.16e-04 | 87 | 139 | 6 | MM15915 | |
| Pathway | WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS | 2.50e-04 | 13 | 139 | 3 | M39527 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 2.63e-04 | 32 | 139 | 4 | M39333 | |
| Pathway | WP_WHITE_FAT_CELL_DIFFERENTIATION | 2.97e-04 | 33 | 139 | 4 | MM15869 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.15e-04 | 14 | 139 | 3 | M27808 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 3.74e-04 | 35 | 139 | 4 | MM15144 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER | 3.74e-04 | 35 | 139 | 4 | M42525 | |
| Pathway | WP_FOXP3_IN_COVID19 | 3.91e-04 | 15 | 139 | 3 | M42573 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 3.91e-04 | 15 | 139 | 3 | MM14536 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 4.17e-04 | 36 | 139 | 4 | M542 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 4.17e-04 | 36 | 139 | 4 | MM1418 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 4.64e-04 | 37 | 139 | 4 | M8615 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 4.78e-04 | 16 | 139 | 3 | M27121 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.78e-04 | 16 | 139 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 4.78e-04 | 16 | 139 | 3 | MM1420 | |
| Pathway | BIOCARTA_ARAP_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M2482 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 5.76e-04 | 17 | 139 | 3 | M47905 | |
| Pathway | REACTOME_FORMATION_OF_PARAXIAL_MESODERM | 5.87e-04 | 69 | 139 | 5 | M46439 | |
| Pathway | WP_IL5_SIGNALING | 6.28e-04 | 40 | 139 | 4 | M39392 | |
| Pathway | WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME | 6.70e-04 | 71 | 139 | 5 | M39860 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | PSMC4 IRF4 KAT2A STAT3 STAT5A STAT5B IQGAP1 MET KAT2B NOTCH1 VCP CAMK2A RNF213 | 6.75e-04 | 464 | 139 | 13 | M27547 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.87e-04 | 18 | 139 | 3 | MM14775 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 6.87e-04 | 18 | 139 | 3 | M673 | |
| Pathway | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | 7.21e-04 | 245 | 139 | 9 | MM15403 | |
| Pathway | WP_IL7_SIGNALING_PATHWAY | 8.29e-04 | 43 | 139 | 4 | MM15864 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 9.14e-04 | 76 | 139 | 5 | MM15520 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.46e-04 | 20 | 139 | 3 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 9.46e-04 | 20 | 139 | 3 | M39002 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 9.46e-04 | 20 | 139 | 3 | MM15496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 9.47e-04 | 5 | 139 | 2 | M49006 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 9.47e-04 | 5 | 139 | 2 | M48986 | |
| Pathway | WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS | 9.47e-04 | 5 | 139 | 2 | M48327 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 9.86e-04 | 45 | 139 | 4 | M47408 | |
| Pathway | REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING | 1.26e-03 | 48 | 139 | 4 | M914 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 1.26e-03 | 22 | 139 | 3 | M42534 | |
| Pathway | WP_IL3_SIGNALING | 1.36e-03 | 49 | 139 | 4 | M39722 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.44e-03 | 23 | 139 | 3 | MM14954 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.63e-03 | 24 | 139 | 3 | M519 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 1.63e-03 | 24 | 139 | 3 | M11520 | |
| Pathway | PID_KIT_PATHWAY | 1.70e-03 | 52 | 139 | 4 | M231 | |
| Pathway | PID_PTP1B_PATHWAY | 1.70e-03 | 52 | 139 | 4 | M50 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 2.93e-09 | 94 | 193 | 9 | 23431145 | |
| Pubmed | EPHX1 PALD1 SEC24A KIF1B PSMC4 DARS1 STAT3 IQGAP1 PGRMC2 XRN1 ARHGAP29 PLEKHA5 LRRC7 NOTCH1 VCP SH3RF1 DSG2 JMJD1C DENND4C MARK2 | 3.27e-09 | 708 | 193 | 20 | 39231216 | |
| Pubmed | Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. | 1.37e-08 | 6 | 193 | 4 | 10485657 | |
| Pubmed | IRF2BP1 MYO1D SEC24A PSMC4 CDK11A IRF4 DARS1 KAT2A WASHC2A STAT3 STAT5A STAT5B SCAF4 KAT2B DDX50 DDX54 XRN1 FOXK1 SCAF8 IRF8 PPP6R1 PPARG JMJD1C GTF3C2 ACTR6 SMARCA2 ZMYM4 | 2.88e-08 | 1429 | 193 | 27 | 35140242 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHX1 USP34 ENPP1 C1GALT1 PTDSS2 NT5DC1 MEST MET P3H1 PIGX PLEKHA5 SGCE NOTCH1 VCP COL4A2 DSG2 RANBP6 RNF213 ST3GAL4 TMEM43 PPP6R1 TMEM87A PACC1 TMEM131 | 6.52e-08 | 1201 | 193 | 24 | 35696571 |
| Pubmed | 1.13e-07 | 9 | 193 | 4 | 10781830 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 RNGTT PSMC4 FANCD2 PTPRO DDX54 XRN1 FOXK1 VCP FLNA FLNC MTMR12 DSG2 POLD1 DUSP14 RANBP6 OAT TMEM43 PPP6R1 THOP1 MARK2 | 1.33e-07 | 974 | 193 | 21 | 28675297 |
| Pubmed | Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. | 1.68e-07 | 3 | 193 | 3 | 20201032 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 25174320 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 24753251 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 10037026 | ||
| Pubmed | Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. | 1.68e-07 | 3 | 193 | 3 | 24091328 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 19796718 | ||
| Pubmed | IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. | 1.68e-07 | 3 | 193 | 3 | 9398404 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 18927468 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 18342552 | ||
| Pubmed | Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse. | 1.88e-07 | 10 | 193 | 4 | 11161808 | |
| Pubmed | 1.88e-07 | 10 | 193 | 4 | 10200816 | ||
| Pubmed | 1.88e-07 | 10 | 193 | 4 | 10825200 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 RNGTT MYO1D MAP1A KIF1B PSMC4 CDK11A WASHC2A FOXK1 SH3RF1 WASHC2C UBE2C PPP6R1 SLFN11 CFAP44 ZMYM4 | 2.17e-07 | 588 | 193 | 16 | 38580884 |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | TBC1D19 MAP1A TRMT11 GBE1 KAT2A STAT3 IQGAP1 JAK3 VCP DOK1 FLNA CD3E | 3.37e-07 | 327 | 193 | 12 | 15592455 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PALD1 AHI1 RNGTT IRF2BP1 KIF1B PSMC4 CDK11A PTDSS2 IQGAP1 SRSF12 KCTD5 PGRMC2 PLEKHA5 FOXK1 VTN SRSF6 CAMK2A POLD1 DENND4C GTF3C2 NANS MARK2 DCTN3 IPO11 | 3.69e-07 | 1321 | 193 | 24 | 27173435 |
| Pubmed | PALD1 USP34 IRF2BP1 ACADM PSMC4 GBE1 STAT3 IQGAP1 FANCD2 DDX50 PGRMC2 DDX54 ATP13A3 VCP FLNA SRSF6 POLD1 NOB1 RANBP6 RNF213 OAT TMEM43 PPP6R1 LTF IPO11 | 4.77e-07 | 1440 | 193 | 25 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 ACADM SEC24A KIF1B TBC1D2 PSMC4 DARS1 CMYA5 WASHC2A STAT3 STAT5B IQGAP1 FANCD2 P3H1 FOXK1 VCP FLNA FLNC SRSF6 POLD1 RANBP6 THOP1 NANS DCTN3 IPO11 | 5.77e-07 | 1455 | 193 | 25 | 22863883 |
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 6.70e-07 | 4 | 193 | 3 | 25205818 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 7719938 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 25352693 | ||
| Pubmed | IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. | 6.70e-07 | 4 | 193 | 3 | 32332067 | |
| Pubmed | HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. | 6.70e-07 | 4 | 193 | 3 | 11485409 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 12605694 | ||
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 6.70e-07 | 4 | 193 | 3 | 15634877 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 23696567 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 17639043 | ||
| Pubmed | STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. | 6.70e-07 | 4 | 193 | 3 | 23716595 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 28422733 | ||
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 1.05e-06 | 33 | 193 | 5 | 8672127 | |
| Pubmed | 1.13e-06 | 242 | 193 | 10 | 34011540 | ||
| Pubmed | 1.34e-06 | 191 | 193 | 9 | 33762435 | ||
| Pubmed | Gcn5 and PCAF regulate PPARγ and Prdm16 expression to facilitate brown adipogenesis. | 1.67e-06 | 5 | 193 | 3 | 25071153 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 18549798 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 23533167 | ||
| Pubmed | Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. | 1.67e-06 | 5 | 193 | 3 | 7568001 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 29794014 | ||
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 1.67e-06 | 5 | 193 | 3 | 19362457 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 9047382 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 15677474 | ||
| Pubmed | Stat5a/b are essential for normal lymphoid development and differentiation. | 1.67e-06 | 5 | 193 | 3 | 16418296 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 23033267 | ||
| Pubmed | Direct interaction between Kit and the interleukin-7 receptor. | 1.67e-06 | 5 | 193 | 3 | 17554063 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 10747963 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 22492969 | ||
| Pubmed | 1.73e-06 | 197 | 193 | 9 | 36604605 | ||
| Pubmed | RNGTT MYO1D SEC24A PSMC4 FANCD2 PHKA1 CACTIN DDX50 P3H1 PGRMC2 DDX54 HSD17B4 NOTCH1 MTMR12 DUSP14 RNF213 PPP6R1 CCNH SLFN11 CTDSPL | 1.80e-06 | 1049 | 193 | 20 | 27880917 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CYTH3 DARS1 PTDSS2 ACVR1 STAT3 SCAF4 SYK PLEKHA5 ST3GAL4 JMJD1C SLC7A2 CD81 MARK2 IPO11 | 2.05e-06 | 536 | 193 | 14 | 15840001 |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 PSMC4 PTDSS2 ACVR1 FANCD2 MET ANKIB1 SGCE ATP13A3 MYRF NOTCH1 VPS18 RANBP6 RNF213 OAT TMEM87A CD81 PACC1 MARK2 IPO11 | 2.14e-06 | 1061 | 193 | 20 | 33845483 |
| Pubmed | CYTH3 DARS1 PTDSS2 ACVR1 STAT3 SCAF4 SYK PLEKHA5 ST3GAL4 JMJD1C SLC7A2 CD81 MARK2 IPO11 | 2.14e-06 | 538 | 193 | 14 | 10512203 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.83e-06 | 268 | 193 | 10 | 33024031 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYO1D KIF1B PSMC4 CMYA5 IQGAP1 MEST MET CACTIN KCTD5 LRRC7 FOXK1 VCP VPS18 SRSF6 CAMK2A POLD1 OAT JMJD1C CCNH LTF MARK2 IPO11 | 3.03e-06 | 1284 | 193 | 22 | 17353931 |
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 3.32e-06 | 6 | 193 | 3 | 14704793 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 17082570 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 21278738 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 12704203 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 10675904 | ||
| Pubmed | Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation. | 3.32e-06 | 6 | 193 | 3 | 19923221 | |
| Pubmed | Nonredundant roles for Stat5a/b in directly regulating Foxp3. | 3.32e-06 | 6 | 193 | 3 | 17227828 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 27870635 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 24166977 | ||
| Pubmed | Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. | 3.32e-06 | 6 | 193 | 3 | 17363300 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 22402124 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 17951529 | ||
| Pubmed | Adaptor proteins NUMB and NUMBL promote cell cycle withdrawal by targeting ERBB2 for degradation. | 3.34e-06 | 19 | 193 | 4 | 28067668 | |
| Pubmed | ACADM ENPP1 STAT5B TMEM62 XRN1 ANKIB1 PLEKHA5 HSD17B4 CDC42BPG MTMR12 VTN SCAF8 PPP6R1 JMJD1C MARK2 | 3.98e-06 | 650 | 193 | 15 | 38777146 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 23797472 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 11735219 | ||
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 5.79e-06 | 7 | 193 | 3 | 12634107 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 5.79e-06 | 7 | 193 | 3 | 10526573 | |
| Pubmed | SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. | 5.79e-06 | 7 | 193 | 3 | 10490100 | |
| Pubmed | Transcriptional and physiological roles for STAT proteins in leptin action. | 5.79e-06 | 7 | 193 | 3 | 30718218 | |
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 5.79e-06 | 7 | 193 | 3 | 12039028 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 5.79e-06 | 7 | 193 | 3 | 24058793 | |
| Pubmed | TBC1D19 KIF1B DARS1 SCAF4 IQGAP1 MET PLEKHA5 FLNA FLNC VTN DSG2 | 6.09e-06 | 360 | 193 | 11 | 33111431 | |
| Pubmed | ACADM MAP1A CYTH2 PSMC4 DARS1 WASHC2A TENM2 MET XRN1 PLCB1 LRRC7 VCP SHANK1 FLNA WASHC2C CAMK2A OAT TMEM43 PPP6R1 SLC6A11 | 6.14e-06 | 1139 | 193 | 20 | 36417873 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MYO1D SEC24A KIF1B WASHC2A STAT3 IQGAP1 XRN1 ARHGAP29 HSD17B4 WASHC2C DSG2 NOB1 PARD3B DYNC2LI1 NANS TMEM131 DCTN3 | 6.26e-06 | 853 | 193 | 17 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SEC24A KIF1B STAT3 STOX2 DENND1B XRN1 PLEKHA5 FOXK1 MTMR12 SH3RF1 HIPK4 DSG2 CAMK2A PARD3B DENND4C MARK2 OTOG | 7.07e-06 | 861 | 193 | 17 | 36931259 |
| Pubmed | Substrate-trapping techniques in the identification of cellular PTP targets. | 7.81e-06 | 49 | 193 | 5 | 15588985 | |
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 9.23e-06 | 8 | 193 | 3 | 9989503 | |
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 10602027 | ||
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 19414010 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.45e-06 | 184 | 193 | 8 | 32908313 | |
| Pubmed | USP34 DCHS2 CYTH3 KIF1B DARS1 CMYA5 STAT3 STAT5B IQGAP1 HPF1 HSD17B4 VCP SHANK1 FOLH1 CAMK2A ZBTB47 OAT THOP1 NETO1 TMEM131 ZMYM4 | 1.06e-05 | 1285 | 193 | 21 | 35914814 | |
| Pubmed | 1.24e-05 | 191 | 193 | 8 | 31177093 | ||
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 23435120 | ||
| Pubmed | The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. | 1.38e-05 | 9 | 193 | 3 | 10506573 | |
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 19734904 | ||
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 17121613 | ||
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 9484840 | ||
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 20065083 | ||
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 17938255 | ||
| Pubmed | USP34 IRF2BP1 GBE1 KAT2A NT5DC1 STAT3 IQGAP1 FANCD2 CACTIN FOXK1 VCP POLD1 UBE2C RNF213 CCNH GTF3C2 NANS SMARCA2 | 1.58e-05 | 1014 | 193 | 18 | 32416067 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | IQGAP1 PGRMC2 XRN1 ARHGAP29 PLEKHA5 LRRC7 NOTCH1 FLNA SH3RF1 DSG2 TMEM87A DENND4C MARK2 | 1.84e-05 | 565 | 193 | 13 | 25468996 |
| Interaction | KCNA3 interactions | EPHX1 PALD1 MYO1D SEC24A KIF1B PSMC4 DARS1 STAT3 IQGAP1 PGRMC2 XRN1 ARHGAP29 PLEKHA5 LRRC7 NOTCH1 VCP SH3RF1 DSG2 RNF213 JMJD1C DENND4C MARK2 OTOG | 6.33e-06 | 871 | 187 | 23 | int:KCNA3 |
| Interaction | IL2RB interactions | 1.95e-05 | 36 | 187 | 5 | int:IL2RB | |
| Interaction | LCK interactions | MYO1D STAT3 STAT5A FANCD2 JAK3 MET DDX54 SYK PLEKHA5 NOTCH1 DOK1 DSG2 SMURF1 CD3E MARK2 | 2.91e-05 | 463 | 187 | 15 | int:LCK |
| Interaction | HSP90AB1 interactions | AHI1 ARHGAP24 CDK11A DARS1 PTDSS2 STAT3 IQGAP1 FANCD2 JAK3 MET NOTCH1 VCP FLNA WASHC2C HIPK4 CAMK2A CRY2 THOP1 NANS UNC13C TSHZ1 MARK2 MAPK7 | 2.98e-05 | 960 | 187 | 23 | int:HSP90AB1 |
| Interaction | ITGB2 interactions | 3.27e-05 | 132 | 187 | 8 | int:ITGB2 | |
| Interaction | RHOC interactions | TENM2 IQGAP1 MET DDX50 PGRMC2 HPF1 DDX54 ATP13A3 NOTCH1 VCP DSG2 PARD3B TMEM87A SLC7A2 TMEM131 MARK2 ZMYM4 | 3.31e-05 | 584 | 187 | 17 | int:RHOC |
| Interaction | ARF6 interactions | PALD1 CYTH2 KAT2A IQGAP1 FANCD2 PGRMC2 DDX54 PLCB1 PLEKHA5 ATP13A3 NOTCH1 VCP DSG2 TMEM87A DENND4C SLC7A2 MARK2 | 3.31e-05 | 584 | 187 | 17 | int:ARF6 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 3.95e-05 | 147 | 193 | 6 | chr15q15 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.02e-04 | 19 | 127 | 3 | 832 | |
| GeneFamily | WASH complex | 7.21e-04 | 6 | 127 | 2 | 1331 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | PALD1 RNGTT C1GALT1 ACVR1 STAT3 MEST MET PGRMC2 XRN1 FOXK1 COL4A2 SRSF6 OAT SLC7A2 SMARCA2 CD81 | 1.53e-07 | 438 | 191 | 16 | M227 |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | CYTH3 SEC24A IRF4 MYSM1 STAT5A MTMR12 SCAF8 RNF213 HELZ2 SMARCA2 TMEM131 | 2.57e-07 | 199 | 191 | 11 | M3417 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | DCHS2 AHI1 TSHZ2 MEST MET STOX2 SGCE C6orf141 FLNC FMOD IRF8 PPARG TSHZ1 CTDSPL | 1.65e-06 | 402 | 191 | 14 | M45754 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | AHI1 ACADM STAT5A STAT5B SRSF12 PADI1 SHANK1 THEMIS RNF213 TMEM131 | 2.16e-06 | 199 | 191 | 10 | M9184 |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | TBC1D19 ARHGAP24 ACADM PTDSS2 CMYA5 STAT5B SRSF12 CRY2 MAPK7 ZMYM4 | 2.16e-06 | 199 | 191 | 10 | M9178 |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN | TBC1D19 EPHX1 AHI1 TSHZ2 CYTH3 ARHGAP29 THEMIS DYNC2LI1 CD81 | 1.64e-05 | 199 | 191 | 9 | M9288 |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 1.71e-05 | 200 | 191 | 9 | M3811 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 1.71e-05 | 200 | 191 | 9 | M6626 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.70e-05 | 212 | 191 | 9 | M39221 | |
| Coexpression | SASAKI_ADULT_T_CELL_LEUKEMIA | 3.38e-05 | 168 | 191 | 8 | M15171 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | PALD1 RNGTT DARS1 C1GALT1 ACVR1 STAT3 MEST MET PGRMC2 XRN1 ARHGAP29 FOXK1 COL4A2 SRSF6 OAT ST3GAL4 SLC7A2 NANS SMARCA2 CD81 | 5.15e-05 | 1009 | 191 | 20 | M157 |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN | 1.11e-04 | 199 | 191 | 8 | M7824 | |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 1.15e-04 | 200 | 191 | 8 | M306 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP | 1.15e-04 | 200 | 191 | 8 | M9944 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M3614 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M8436 | |
| Coexpression | GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP | 1.15e-04 | 200 | 191 | 8 | M8532 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN | 1.15e-04 | 200 | 191 | 8 | M7426 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN | 1.15e-04 | 200 | 191 | 8 | M7423 | |
| Coexpression | GSE3982_DC_VS_MAC_LPS_STIM_UP | 1.15e-04 | 200 | 191 | 8 | M5387 | |
| Coexpression | GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN | 1.15e-04 | 200 | 191 | 8 | M7819 | |
| Coexpression | URS_ADIPOCYTE_DIFFERENTIATION_UP | 1.22e-04 | 66 | 191 | 5 | M15476 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | MAP1A TSHZ2 ACVR1 FREM1 MYRF FLNA FLNC TRPC7 SLC27A6 RNF213 SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 4.38e-08 | 418 | 190 | 18 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | MAP1A TSHZ2 ACVR1 FREM1 MYRF FLNA FLNC HMCN1 CLCA2 CDH6 CDH10 | 2.75e-06 | 207 | 190 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | TSHZ2 ENPP1 FREM1 PTPRO ARHGAP29 SGCE ATP13A3 MYRF FLNA FLNC SLC27A6 RNF213 OAT DENND4C SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 | 3.21e-06 | 740 | 190 | 21 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | FREM1 ARHGAP29 SLC27A6 RNF213 SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 | 4.07e-06 | 137 | 190 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | TSHZ2 FREM1 ARHGAP29 FLNC SLC27A6 RNF213 DENND4C SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 | 4.36e-06 | 357 | 190 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | MAP1A TSHZ2 ACVR1 FREM1 DENND1B P3H1 ARHGAP29 MYRF FLNA FLNC TRPC7 SLC27A6 RNF213 ST3GAL4 SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 5.21e-06 | 827 | 190 | 22 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 6.16e-06 | 183 | 190 | 10 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_200 | 9.50e-06 | 152 | 190 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | FREM1 ARHGAP29 MYRF FLNC SLC27A6 RNF213 SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 1.12e-05 | 388 | 190 | 14 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.30e-05 | 158 | 190 | 9 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.51e-05 | 161 | 190 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.58e-05 | 162 | 190 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | EPHX1 ARHGAP24 MYO1D MAP1A TSHZ2 C1GALT1 FREM1 STOX2 P3H1 MYRF COL4A2 FLNA FLNC FMOD SLC27A6 RNF213 DEPDC1 HMCN1 CLCA2 CDH6 | 2.30e-05 | 777 | 190 | 20 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_1000 | TSHZ2 ACVR1 FREM1 STAT3 STOX2 DENND1B MYRF SPTY2D1 FLNC TRPC7 SLC27A6 DSG2 RNF213 ST3GAL4 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 2.56e-05 | 849 | 190 | 21 | gudmap_dev gonad_e11.5_M_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | TSHZ2 FREM1 DENND1B ARHGAP29 ATP13A3 MYRF FLNA FLNC SLC27A6 RNF213 OAT DENND4C SLC7A2 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 2.57e-05 | 783 | 190 | 20 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | FREM1 ARHGAP29 MYRF FLNA FLNC SLC27A6 RNF213 SLC7A2 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 2.92e-05 | 423 | 190 | 14 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | MYO1D MAP1A FREM1 STAT3 DENND1B P3H1 MYRF SPTY2D1 FLNA FLNC TRPC7 SLC27A6 DSG2 RNF213 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 2.99e-05 | 858 | 190 | 21 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500 | FREM1 MYRF SPTY2D1 FLNC TRPC7 DSG2 RNF213 ST3GAL4 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 3.67e-05 | 432 | 190 | 14 | gudmap_dev gonad_e11.5_M_GonMes_Sma_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 4.50e-05 | 143 | 190 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_100 | 4.54e-05 | 72 | 190 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | FREM1 ARHGAP29 MYRF FLNC TRPC7 RNF213 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 4.61e-05 | 385 | 190 | 13 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100 | 4.91e-05 | 73 | 190 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 7.96e-05 | 26 | 190 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | MYO1D MAP1A TSHZ2 C1GALT1 ACVR1 FREM1 STOX2 MYRF FLNA FLNC FMOD SLC27A6 RNF213 DEPDC1 HMCN1 CLCA2 PACC1 CDH6 CDH10 | 9.64e-05 | 793 | 190 | 19 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | MAP1A TSHZ2 ENPP1 FREM1 ARHGAP29 MYRF FLNA FLNC TRPC7 FMOD SLC27A6 RNF213 DENND4C HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 | 1.03e-04 | 797 | 190 | 19 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | TSHZ2 ACVR1 FREM1 STOX2 MYRF SPTY2D1 FLNC HMCN1 CLCA2 CDH6 CDH10 | 1.19e-04 | 311 | 190 | 11 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | TSHZ2 FREM1 ARHGAP29 MYRF FLNC RNF213 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 | 1.39e-04 | 372 | 190 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 1.42e-04 | 30 | 190 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_500 | FREM1 DENND1B MYRF FLNC TRPC7 DSG2 RNF213 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 1.60e-04 | 436 | 190 | 13 | gudmap_dev gonad_e11.5_F_GonMes_Sma_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | MYO1D MAP1A FREM1 MYRF SPTY2D1 FLNA FLNC HMCN1 CLCA2 CDH6 CDH10 | 1.84e-04 | 327 | 190 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | GDPD1 ENPP1 KIF1B TBC1D2 GBE1 STAT5A IQGAP1 MET DENND1B PLCD1 SPTY2D1 GPLD1 FMOD SH3RF1 DSG2 DUSP14 PPARG CLCA2 | 2.34e-04 | 780 | 190 | 18 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | MAP1A TSHZ2 ACVR1 FREM1 MYRF FLNA FLNC HMCN1 CLCA2 CDH6 CDH10 | 2.39e-04 | 337 | 190 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | GDPD1 MAP1A FREM1 ARHGAP29 MYRF FLNA FLNC TRPC7 SLC27A6 DSG2 RNF213 HMCN1 CLCA2 ACTR6 PACC1 TSHZ1 CDH6 CDH10 | 3.04e-04 | 797 | 190 | 18 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.50e-04 | 146 | 190 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | TSHZ2 FREM1 STOX2 FLNA FLNC SLC27A6 RNF213 ST3GAL4 HMCN1 CLCA2 PACC1 | 4.58e-04 | 364 | 190 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 4.64e-04 | 153 | 190 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | USP34 KIF1B ACVR1 FREM1 FANCD2 MEST SPTY2D1 NAALAD2 RANBP6 CDH10 | 4.65e-04 | 307 | 190 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | TSHZ2 FREM1 ARHGAP29 MYRF FLNA FLNC TRPC7 SLC27A6 RNF213 SLC7A2 HMCN1 CLCA2 ACTR6 SMARCA2 PACC1 TSHZ1 CDH6 CDH10 | 4.98e-04 | 831 | 190 | 18 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 5.33e-04 | 42 | 190 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | PALD1 AHI1 ARHGAP24 KIF1B TENM2 FREM1 FANCD2 PTPRO PLCB1 ATP13A3 SPTY2D1 NAALAD2 IRF8 PARD3B RIMS2 CDH6 FRMD3 IPO11 | 5.35e-04 | 836 | 190 | 18 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.68e-04 | 114 | 190 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200 | 6.01e-04 | 76 | 190 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | EPHX1 ARHGAP24 TSHZ2 ACVR1 FREM1 STOX2 P3H1 FLNA FLNC NAALAD2 SLC27A6 RNF213 DEPDC1 ST3GAL4 SLC7A2 HMCN1 CLCA2 | 6.04e-04 | 773 | 190 | 17 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 6.15e-04 | 19 | 190 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#3 | SEC24A CYTH2 PSMC4 KCTD5 DDX54 ARHGAP29 FLNA SCAF8 UBE2C NOB1 CCNH THOP1 HMCN1 NANS ACTR6 MARK2 | 6.56e-04 | 708 | 190 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.62e-04 | 265 | 190 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.28e-04 | 165 | 190 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 7.60e-04 | 80 | 190 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.81e-04 | 167 | 190 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 8.12e-04 | 122 | 190 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 8.33e-04 | 21 | 190 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_100 | 8.50e-04 | 82 | 190 | 5 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_100 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | DCHS2 MYO1D TBC1D2 ACVR1 IQGAP1 MET PLEKHA5 CDC42BPG DSG2 RIMS2 | 8.36e-09 | 184 | 193 | 10 | d9659d1e4465fec68f48a22edef443f354f6c7cf |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 194 | 193 | 9 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.09e-07 | 197 | 193 | 9 | c838d0f64e3b43a616a9e381b8139bfe9aa32da7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 182 | 193 | 8 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 1.34e-06 | 182 | 193 | 8 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 193 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 1.51e-06 | 185 | 193 | 8 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 189 | 193 | 8 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 194 | 193 | 8 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-06 | 194 | 193 | 8 | 2172d951896265243d14996eacce5aab5e14e26e | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 194 | 193 | 8 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-06 | 195 | 193 | 8 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 195 | 193 | 8 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 195 | 193 | 8 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 196 | 193 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 198 | 193 | 8 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.61e-06 | 199 | 193 | 8 | cdcdef1d95a8e476de016b1e11ee010438834be0 | |
| ToppCell | mild-MAIT|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-06 | 200 | 193 | 8 | 1e3ef15ce48b9a19a6ac3e08ea0234a9376e6596 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Suprabasal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 200 | 193 | 8 | d536180a308abc5703d5c8bb33dfe57dc4cc6577 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.68e-06 | 157 | 193 | 7 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-06 | 164 | 193 | 7 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-06 | 168 | 193 | 7 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.55e-06 | 170 | 193 | 7 | 71718dcebd48105994c313bb55babc70301170a0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-06 | 171 | 193 | 7 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.92e-06 | 171 | 193 | 7 | 121e63ca281ad765d76c2afb3b4d441329b47f81 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 175 | 193 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-05 | 176 | 193 | 7 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-05 | 178 | 193 | 7 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-05 | 179 | 193 | 7 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 180 | 193 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.43e-05 | 181 | 193 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 182 | 193 | 7 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-05 | 182 | 193 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 1.60e-05 | 184 | 193 | 7 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 184 | 193 | 7 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-05 | 184 | 193 | 7 | 89302321b0949d5b57047b75dd16049aac9a2a3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 184 | 193 | 7 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 1.65e-05 | 185 | 193 | 7 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 186 | 193 | 7 | eeacf59a9e6bf1c9fd59b6b13d35e8abae228cf0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-05 | 186 | 193 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 187 | 193 | 7 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 187 | 193 | 7 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.77e-05 | 187 | 193 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-05 | 188 | 193 | 7 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 188 | 193 | 7 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.83e-05 | 188 | 193 | 7 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-05 | 189 | 193 | 7 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-05 | 189 | 193 | 7 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.96e-05 | 190 | 193 | 7 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 191 | 193 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 192 | 193 | 7 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 192 | 193 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.10e-05 | 192 | 193 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-05 | 193 | 193 | 7 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-05 | 193 | 193 | 7 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 193 | 193 | 7 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 194 | 193 | 7 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.24e-05 | 194 | 193 | 7 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 194 | 193 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-05 | 194 | 193 | 7 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 194 | 193 | 7 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-05 | 194 | 193 | 7 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 195 | 193 | 7 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.32e-05 | 195 | 193 | 7 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 195 | 193 | 7 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 195 | 193 | 7 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-05 | 195 | 193 | 7 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-05 | 195 | 193 | 7 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 196 | 193 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.40e-05 | 196 | 193 | 7 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.40e-05 | 196 | 193 | 7 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.40e-05 | 196 | 193 | 7 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | COPD-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.40e-05 | 196 | 193 | 7 | c9bdd505c3ab380ed7b272aa518df31a0a706a06 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 197 | 193 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.47e-05 | 197 | 193 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 197 | 193 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 197 | 193 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 197 | 193 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 198 | 193 | 7 | 240e1aa0594ee6de530b2f97d5e392c5fcbf278b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 198 | 193 | 7 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 198 | 193 | 7 | 9a229167d4da4abf8c336dfe5cfdf57db756fc8b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 198 | 193 | 7 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-05 | 198 | 193 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-05 | 198 | 193 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 2.56e-05 | 198 | 193 | 7 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-05 | 198 | 193 | 7 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-05 | 198 | 193 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 134 | 193 | 6 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 199 | 193 | 7 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 199 | 193 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 2.64e-05 | 199 | 193 | 7 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 199 | 193 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 199 | 193 | 7 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 2.64e-05 | 199 | 193 | 7 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.73e-05 | 200 | 193 | 7 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.73e-05 | 200 | 193 | 7 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| Drug | AZD 1480 | 2.27e-06 | 4 | 190 | 3 | ctd:C545606 | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | STAT5B CACTIN PLCB1 DOK1 GPLD1 SMURF1 MARK2 RIMS2 CTDSPL CDH6 | 5.64e-06 | 194 | 190 | 10 | 5457_DN |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 6.75e-06 | 198 | 190 | 10 | 7178_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 6.75e-06 | 198 | 190 | 10 | 3626_DN | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | TBC1D19 USP34 PTDSS2 MET CACTIN DDX54 SYK PADI1 SMARCA2 CTDSPL | 7.37e-06 | 200 | 190 | 10 | 3552_DN |
| Drug | Proline | 1.01e-05 | 164 | 190 | 9 | CID000000614 | |
| Disease | Liver neoplasms | 3.79e-06 | 142 | 188 | 8 | C0023903 | |
| Disease | Malignant neoplasm of liver | 3.79e-06 | 142 | 188 | 8 | C0345904 | |
| Disease | Lymphatic Metastasis | 2.14e-05 | 26 | 188 | 4 | C0024232 | |
| Disease | apolipoprotein B measurement | TDRD15 DCHS2 CYP7A1 STAT3 SCAF4 IQGAP1 CILP2 MYRF SPTY2D1 COL4A2 VTN ST3GAL4 PPARG GTF3C2 DYNC2LI1 | 2.50e-05 | 663 | 188 | 15 | EFO_0004615 |
| Disease | T-Cell Large Granular Lymphocyte Leukemia | 4.04e-05 | 2 | 188 | 2 | C1955861 | |
| Disease | Autistic Disorder | 4.86e-05 | 261 | 188 | 9 | C0004352 | |
| Disease | Colonic Neoplasms | 5.66e-05 | 152 | 188 | 7 | C0009375 | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 TDRD15 CYP7A1 STAT3 SCAF4 XRN1 MYRF SPTY2D1 COL4A2 VTN ST3GAL4 PPARG DENND4C THOP1 MARK2 | 5.70e-05 | 713 | 188 | 15 | EFO_0005689 |
| Disease | testosterone measurement | DCHS2 IRF2BP1 MAP1A TSHZ2 CYP7A1 ASCL5 DAO IQGAP1 KAT2B DENND1B PLCB1 COL4A2 TRPC7 SLC27A6 PPARG JMJD1C THOP1 GTF3C2 HMCN1 SMARCA2 SPIN3 | 6.88e-05 | 1275 | 188 | 21 | EFO_0004908 |
| Disease | Malignant tumor of colon | 7.52e-05 | 159 | 188 | 7 | C0007102 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 9.45e-05 | 222 | 188 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.21e-04 | 3 | 188 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Nasal Type Extranodal NK/T-Cell Lymphoma | 1.21e-04 | 3 | 188 | 2 | C0392788 | |
| Disease | cholesteryl ester 15:0 measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0021434 | |
| Disease | Lymphoma, Extranodal NK-T-Cell | 1.21e-04 | 3 | 188 | 2 | C1955906 | |
| Disease | primary angle-closure glaucoma (is_implicated_in) | 1.21e-04 | 3 | 188 | 2 | DOID:1405 (is_implicated_in) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.21e-04 | 3 | 188 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | platelet-derived growth factor receptor-like protein measurement | 1.21e-04 | 3 | 188 | 2 | EFO_0801889 | |
| Disease | T-Cell Lymphoma | 1.34e-04 | 16 | 188 | 3 | C0079772 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 1.34e-04 | 16 | 188 | 3 | C0334634 | |
| Disease | Necrotizing Enterocolitis | 1.62e-04 | 17 | 188 | 3 | C0520459 | |
| Disease | melanoma | 2.02e-04 | 248 | 188 | 8 | C0025202 | |
| Disease | Giant Cell Glioblastoma | 2.04e-04 | 84 | 188 | 5 | C0334588 | |
| Disease | congenital diaphragmatic hernia (is_implicated_in) | 2.40e-04 | 4 | 188 | 2 | DOID:3827 (is_implicated_in) | |
| Disease | sperm acrosome membrane-associated protein 3 measurement | 2.40e-04 | 4 | 188 | 2 | EFO_0802081 | |
| Disease | Crohn Disease | 2.92e-04 | 50 | 188 | 4 | C0010346 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.08e-04 | 264 | 188 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | Acute Lung Injury | 3.59e-04 | 22 | 188 | 3 | C0242488 | |
| Disease | adult T-cell leukemia/lymphoma (is_implicated_in) | 3.99e-04 | 5 | 188 | 2 | DOID:0050523 (is_implicated_in) | |
| Disease | suicide ideation measurement | 3.99e-04 | 5 | 188 | 2 | EFO_0007619 | |
| Disease | Leukemia, T-Cell | 3.99e-04 | 5 | 188 | 2 | C0023492 | |
| Disease | Adenoid Cystic Carcinoma | 4.59e-04 | 100 | 188 | 5 | C0010606 | |
| Disease | lateral orbital frontal cortex volume measurement | 4.67e-04 | 24 | 188 | 3 | EFO_0010312 | |
| Disease | Grade I Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C1704230 | |
| Disease | Pilocytic Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0334583 | |
| Disease | Childhood Cerebral Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0338070 | |
| Disease | Cerebral Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0750936 | |
| Disease | Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0004114 | |
| Disease | Subependymal Giant Cell Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 5.28e-04 | 25 | 188 | 3 | C0547065 | |
| Disease | Juvenile Pilocytic Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 5.28e-04 | 25 | 188 | 3 | C0280785 | |
| Disease | multiple myeloma (is_implicated_in) | 5.52e-04 | 59 | 188 | 4 | DOID:9538 (is_implicated_in) | |
| Disease | Crohn's disease | USP34 TSHZ2 IRF4 STAT3 STAT5B DENND1B MYRF NOTCH1 THEMIS SMURF1 | 5.65e-04 | 441 | 188 | 10 | EFO_0000384 |
| Disease | Gemistocytic astrocytoma | 5.94e-04 | 26 | 188 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 5.94e-04 | 26 | 188 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 5.94e-04 | 26 | 188 | 3 | C0334582 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 5.94e-04 | 26 | 188 | 3 | DOID:234 (is_implicated_in) | |
| Disease | proliferative diabetic retinopathy (is_implicated_in) | 5.96e-04 | 6 | 188 | 2 | DOID:13207 (is_implicated_in) | |
| Disease | Bare Lymphocyte Syndrome | 5.96e-04 | 6 | 188 | 2 | C0242583 | |
| Disease | alkaline phosphatase measurement, liver enzyme measurement | 5.96e-04 | 6 | 188 | 2 | EFO_0004533, EFO_0004582 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.26e-04 | 225 | 188 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | Anaplastic astrocytoma | 6.65e-04 | 27 | 188 | 3 | C0334579 | |
| Disease | free androgen index | 7.00e-04 | 374 | 188 | 9 | EFO_0007005 | |
| Disease | biological sex | 7.13e-04 | 230 | 188 | 7 | PATO_0000047 | |
| Disease | Glioblastoma Multiforme | 7.39e-04 | 111 | 188 | 5 | C1621958 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 7.74e-04 | 169 | 188 | 6 | DOID:3908 (is_marker_for) | |
| Disease | free cholesterol measurement | 8.01e-04 | 113 | 188 | 5 | EFO_0008591 | |
| Disease | cytotoxicity measurement, response to clozapine | 8.23e-04 | 29 | 188 | 3 | EFO_0006952, GO_0097338 | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 8.30e-04 | 7 | 188 | 2 | cv:C0349788 | |
| Disease | beta-citrylglutamate measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0800060 | |
| Disease | neutropenia (implicated_via_orthology) | 8.30e-04 | 7 | 188 | 2 | DOID:1227 (implicated_via_orthology) | |
| Disease | CUB domain-containing protein 1 measurement | 8.30e-04 | 7 | 188 | 2 | EFO_0802432 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 9.10e-04 | 30 | 188 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 9.10e-04 | 30 | 188 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 9.74e-04 | 118 | 188 | 5 | EFO_0010119 | |
| Disease | severe pre-eclampsia (is_marker_for) | 1.10e-03 | 8 | 188 | 2 | DOID:13129 (is_marker_for) | |
| Disease | breast cancer anti-estrogen resistance protein 3 measurement | 1.10e-03 | 8 | 188 | 2 | EFO_0008040 | |
| Disease | eosinophil count | GDPD1 IRF4 ACVR1 STAT5B CILP2 DENND1B PIGX XRN1 MMP17 MYRF NOTCH1 TBX6 GPLD1 FLNA SMURF1 RANBP6 PPARG HELZ2 TMEM131 LTF | 1.36e-03 | 1488 | 188 | 20 | EFO_0004842 |
| Disease | behavioural disinhibition measurement | 1.36e-03 | 75 | 188 | 4 | EFO_0006946 | |
| Disease | Malignant neoplasm of breast | ACADM TRMT11 ACVR1 STAT3 STAT5A ARHGAP29 PLCB1 LRRC7 NOTCH1 FLNA UBE2C IRF8 CCNH CLCA2 PACC1 CDH10 | 1.49e-03 | 1074 | 188 | 16 | C0006142 |
| Disease | Glioblastoma | 1.65e-03 | 79 | 188 | 4 | C0017636 | |
| Disease | ovarian neoplasm | 1.71e-03 | 134 | 188 | 5 | C0919267 | |
| Disease | OBESITY | 1.76e-03 | 10 | 188 | 2 | 601665 | |
| Disease | fetuin-B measurement | 1.76e-03 | 10 | 188 | 2 | EFO_0008128 | |
| Disease | Inherited obesity | 1.76e-03 | 10 | 188 | 2 | cv:C4054476 | |
| Disease | Obesity | 1.76e-03 | 10 | 188 | 2 | cv:C0028754 | |
| Disease | Malignant neoplasm of ovary | 1.89e-03 | 137 | 188 | 5 | C1140680 | |
| Disease | Lymphoma | 2.11e-03 | 40 | 188 | 3 | C0024299 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.14e-03 | 11 | 188 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | gastrin-releasing peptide measurement | 2.14e-03 | 11 | 188 | 2 | EFO_0022000 | |
| Disease | Bipolar I disorder | 2.14e-03 | 11 | 188 | 2 | C0853193 | |
| Disease | Copper-Overload Cirrhosis | 2.14e-03 | 11 | 188 | 2 | C1876165 | |
| Disease | response to anticonvulsant | 2.16e-03 | 85 | 188 | 4 | GO_0036277 | |
| Disease | alkaline phosphatase measurement | USP34 TDRD15 MAP1A NT5DC1 CILP2 MYRF NOTCH1 COL4A2 GPLD1 TRIM41 ST3GAL4 PPARG JMJD1C UNC13C LTF | 2.25e-03 | 1015 | 188 | 15 | EFO_0004533 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.42e-03 | 145 | 188 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | colorectal cancer, endometrial neoplasm | 2.43e-03 | 42 | 188 | 3 | EFO_0004230, MONDO_0005575 | |
| Disease | aortic stenosis, aortic valve calcification | 2.43e-03 | 42 | 188 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 2.56e-03 | 12 | 188 | 2 | EFO_0008258 | |
| Disease | unipolar depression, multiple sclerosis | 2.56e-03 | 12 | 188 | 2 | EFO_0003761, MONDO_0005301 | |
| Disease | obesity (implicated_via_orthology) | 2.63e-03 | 215 | 188 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | IIeocolitis | 2.78e-03 | 44 | 188 | 3 | C0949272 | |
| Disease | glioblastoma (is_marker_for) | 2.78e-03 | 44 | 188 | 3 | DOID:3068 (is_marker_for) | |
| Disease | Crohn's disease of the ileum | 2.78e-03 | 44 | 188 | 3 | C0267380 | |
| Disease | Regional enteritis | 2.78e-03 | 44 | 188 | 3 | C0678202 | |
| Disease | Crohn's disease of large bowel | 2.78e-03 | 44 | 188 | 3 | C0156147 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.96e-03 | 152 | 188 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.97e-03 | 45 | 188 | 3 | EFO_0022236 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.01e-03 | 13 | 188 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FRYRGYPELKEPSGF | 451 | Q0P6H9 | |
| DEIKDPSGLFYILPF | 46 | Q9GZN1 | |
| YEPLEFIDPSRNLGY | 646 | Q76B58 | |
| PFEGFLIDLKTRYPI | 166 | P51946 | |
| GVYEYPFEPAFIQKR | 146 | Q7RTU5 | |
| TIYSPGFPDEYPILK | 2156 | Q96PZ7 | |
| YSDLPFKSPIRDISY | 881 | Q8N157 | |
| ILYPKPTDFKLYRDA | 396 | Q9H7F0 | |
| NGIVEDYKPPFYDVV | 421 | Q04771 | |
| PYALPKEERDRYRGE | 171 | P08572 | |
| TPYGIVPDVYEKESR | 176 | O95147 | |
| EEIFGPVLSVYVYPD | 446 | P30038 | |
| YAALDKREPYEGLRP | 216 | Q9P2G1 | |
| EYDKTGEYPVPLIRR | 66 | P11310 | |
| SFLYRVVREEYFPPK | 171 | P21730 | |
| KTRGNPYRYELIDIP | 196 | Q8N865 | |
| YYLLDEKSPLPVAFE | 316 | P52569 | |
| YLELGDKPAPNTFYV | 46 | P60033 | |
| AEKGSFPDIIIYEYP | 201 | Q96MT7 | |
| IGLPKIFYPETTDIY | 126 | P46940 | |
| YLGALVDAYPIKPEA | 11 | Q9NRI6 | |
| KYPPDRECIYIIEAA | 61 | Q8TDF5 | |
| FPYKRILGPDFGYVT | 381 | Q9ULC6 | |
| LDKDYYVVREPGQSP | 976 | P52333 | |
| EAPDYYEVIRFPIDL | 761 | Q92830 | |
| VKEPPAYTFRDYSAI | 601 | Q32P28 | |
| YFRDSPDEFPVYVGI | 131 | Q9NWY4 | |
| RPVYTLKEAYDNGLP | 1076 | Q6DT37 | |
| EEVYKRPLFLQPTYR | 251 | Q9ULE6 | |
| KLTPRELDMFPDYGY | 116 | P14920 | |
| RVIFDDYKPYLRLDP | 11 | Q96TA0 | |
| QKTLPEYTGYRPFLD | 301 | Q9NRD9 | |
| AYPPVFYLNKDTGEI | 206 | Q14126 | |
| LRPTVPYGEFKSVYV | 121 | Q13164 | |
| YLPAAPRGLYKEREL | 1096 | Q8TEW8 | |
| EEPTGYIRFEKFLPV | 201 | Q5VUJ9 | |
| VYTVPDSYFRGAPKL | 256 | Q06828 | |
| YELRFKEPLPEYVRL | 51 | Q9ULX3 | |
| IYFPEIKRDPGRYLH | 181 | Q5TFE4 | |
| IFPYYGREEELRKHP | 1616 | P46531 | |
| PYSPLGKDYRKAEGE | 1901 | P78559 | |
| PKEFYELDLSLLAPY | 161 | Q15013 | |
| PPGIYKGDYLKELFR | 161 | O60942 | |
| LDISDPYKVYRIVPE | 116 | Q15306 | |
| EAPGYYEVIRFPMDL | 756 | Q92831 | |
| VKEPYIQSRFYRAPE | 171 | Q8NE63 | |
| VPFEDGKPFDLRIYV | 81 | A8MUM7 | |
| FLDGIYKTIHRPPYE | 296 | Q9C0I1 | |
| IAKDLISPRAYRGYP | 1066 | Q96NW7 | |
| PYADPEEIRPKEVYL | 351 | P43405 | |
| RRPYVFIYNSDKDPV | 1726 | O60333 | |
| EDPNRLYYEPAELKL | 306 | P46020 | |
| PDIYYKIFTHRPIED | 81 | Q8NCR3 | |
| LPYVFKGIIEGERYP | 771 | Q9UI26 | |
| ARYEDLLKSLPLPEY | 2276 | Q15652 | |
| ILYSDPADYFAPGVK | 226 | Q04609 | |
| YIPYRPKDFDSERGL | 681 | Q8TDD1 | |
| EPPKPTLALEYTYGR | 56 | Q8TCX1 | |
| VGPSYFVEYLIKESP | 201 | Q9UGM5 | |
| GLLQTYFRKYPDTPV | 226 | Q8N140 | |
| LDISEPYKVYRIVPE | 101 | Q02556 | |
| HYGYKLFIPDRDLIP | 441 | Q9NZN1 | |
| YVGRLLKPGEEPSEY | 196 | O15173 | |
| YTAPEPGKYVITIRF | 1706 | Q14315 | |
| SPREKIYYVFERLPQ | 1306 | Q5H8C1 | |
| DYFLDLPEPLLTFEY | 281 | Q5TB30 | |
| YCELPPYLGKLDVSF | 106 | Q8N9F7 | |
| KDERPHFYTLYLEEP | 361 | P22413 | |
| PYALEYKLVSLPFGI | 5531 | Q96RW7 | |
| IYDYKPSPETGVLFE | 126 | Q16827 | |
| KEVDRYDAPGIALYP | 106 | Q9H813 | |
| FERPKYTFLVYEDVP | 876 | Q6V1P9 | |
| RAIRDYAFKASPYPV | 371 | P51178 | |
| EDGRPRNPYVKIYFL | 836 | Q9UQ26 | |
| RNPYVKIYFLPDRSD | 841 | Q9UQ26 | |
| IYEDSERYPGIPERF | 66 | A0A075B6J6 | |
| PEPFILFRLYKEFID | 751 | Q52LW3 | |
| RELPEPVIPYAKYED | 216 | Q8N264 | |
| KYLDPEYIDRIAIPD | 66 | O75935 | |
| SLLEKDYFGIRYVDP | 66 | A2A2Y4 | |
| LLEIDPYLKPYAVDF | 31 | Q04446 | |
| EEYLEYKKRVPTGLP | 261 | O60725 | |
| PGSFYEFYKIIPLLT | 151 | P07099 | |
| ARVKEEGYELPYNPA | 391 | Q99704 | |
| AADPPKYVLVRVEDY | 151 | Q5SZD1 | |
| TDPSGDYIRRYLPKL | 441 | Q49AN0 | |
| EYYVDDPPRIVLDKL | 46 | P30047 | |
| LYGFDIPLTPREFEK | 876 | Q5THR3 | |
| DPRFYYLGPFKDTTI | 356 | Q9Y6N8 | |
| PAKYLLPEVTVLDYG | 91 | O15194 | |
| PVLPGDYSILVKYNE | 1926 | P21333 | |
| KLPPFSYAYTELEAI | 331 | P51659 | |
| PPALAFLYKDLYEEA | 3186 | Q8N3K9 | |
| YFEYTTDKEPRGIIP | 291 | Q99418 | |
| SVPAKLPEIEEYYDG | 656 | Q9BQ39 | |
| YFEYTTDKEPRGIIP | 296 | O43739 | |
| LIFRYPEEDYESFPL | 211 | Q5VZ89 | |
| PEFGSKLASVPEYRY | 451 | P85037 | |
| PDYEPIRKGQRDLYS | 186 | P07766 | |
| LAREYGSPLKAYTPV | 571 | Q9UQ88 | |
| YVEPLPDYKDPRRTE | 316 | Q7KZI7 | |
| LIDRDPTYFGPVLNY | 91 | Q9NXV2 | |
| PLFYRDPLKTISDPY | 376 | A4D0S4 | |
| FYPDLIDKRSTPEYF | 681 | Q8WUQ7 | |
| YDPEEPIYFGRRFKP | 186 | Q9NS00 | |
| KVEASNPYVEPRFLY | 346 | P55285 | |
| LDPEIYPDPLTFKYD | 396 | P22680 | |
| KYSGVLDSPYERPAL | 66 | A6NMB9 | |
| FYYPLGIVREVLPEA | 1276 | Q9BYK8 | |
| YRDALRYKPGEPITF | 341 | Q6P3S1 | |
| PEYKVPGLYVIDSIV | 56 | O95104 | |
| PEYKVPGLYVIDSIV | 56 | Q9UPN6 | |
| NPYRYPEIKEELEEL | 136 | P37088 | |
| VIEPLKGYYDVPIAT | 586 | P28340 | |
| VNPYPEFLELYRKTL | 286 | Q5EB52 | |
| ATARPPGYEFELKLF | 261 | Q8IU81 | |
| FPFPVKALYGLEEYD | 676 | Q9BXW9 | |
| FIYIRPKASYDPATD | 256 | Q96KK4 | |
| YKIIPPYTDDAFEIR | 596 | Q6ZRI0 | |
| YEVGFLKYGAFVPPE | 486 | Q86XP0 | |
| DVLPEFRDSYPIKYV | 236 | P08581 | |
| YFDAIITDPPYGIRE | 301 | Q7Z4G4 | |
| SPSEKPRRFGVYLDY | 571 | Q8WV44 | |
| PKYPEVGDLRVSFSY | 231 | Q9BTV4 | |
| GPEPEDLEDLYSRYK | 31 | P43686 | |
| VFIQLPSRKELPEYY | 1426 | P51531 | |
| GFIYEAGLAPYKLRP | 81 | P02788 | |
| PYKEYIFRPGTVLEV | 746 | B5MCY1 | |
| DPLRYGLPYEDKVRV | 276 | Q9ULZ9 | |
| VPEEFLYNPLTRVYG | 461 | O95486 | |
| IPFTRTDPVVADYKY | 81 | P37231 | |
| YVDPKLGVPLPERDY | 156 | Q9BVG9 | |
| SREDRYIELFYFPIP | 26 | Q11206 | |
| SEYQKLFPDIPIGYS | 201 | Q9NR45 | |
| KDYLEYGEILPFPES | 196 | Q7Z7L1 | |
| PLPVDLYRYDEISGK | 2111 | Q9NT68 | |
| DGPKYRYVFEDPDVV | 96 | A0A087WV53 | |
| LIYVFPDRPKDEVYS | 666 | P51692 | |
| TDFYILDKYPLAVRP | 386 | P14868 | |
| KYGPPVRTEYRLIVE | 101 | Q13247 | |
| TPGYLSPEVLRKDPY | 176 | Q9UQM7 | |
| PFPTGYKRQREYEEE | 576 | Q68D10 | |
| IADTVPKYLGPYLED | 251 | O60518 | |
| GPPTSDDIFEREYKY | 36 | P04181 | |
| VLEREYFKGEFPPYP | 61 | O43556 | |
| GRYGPIVDVYIPLDF | 31 | Q8WXF0 | |
| FNRIDIPPYESYEKL | 726 | Q9HCE7 | |
| VAIYPYTPRKEDELE | 451 | Q7Z6J0 | |
| YPQSFEKGVPYLEFR | 141 | Q9Y566 | |
| GDLSYLIYVFPDRPK | 661 | P42229 | |
| KYEYNVVPFREGTPA | 906 | Q8IUL8 | |
| PEIILFDPDGRKYYT | 536 | Q9UQC9 | |
| PDKPGVYTRVTAYLD | 396 | O60235 | |
| YRDKIPEEALSPSYL | 831 | Q63HN8 | |
| PKDFYGTLILKPVYE | 216 | Q8N1K5 | |
| IKQDIPAGLYVDPYE | 81 | Q8TBF5 | |
| YVRELPAFKDAVPEY | 1671 | Q8NB66 | |
| KPYFLEAYRPIRKGD | 136 | P55072 | |
| ERKIYPTPDGYFIVT | 126 | Q9P2F5 | |
| VPVNPSLYLIKYDGF | 76 | Q5JUX0 | |
| VYLYPDIPKEEAFGK | 671 | P40763 | |
| KYPAPERLQEYGSIF | 106 | A8MWX3 | |
| PDLYFRPLYVLNEEG | 186 | Q9P253 | |
| GFLDYFVLPPKIEER | 536 | Q92545 | |
| DEKKSLGRVYGYFPP | 616 | P80108 | |
| IIEYYPPDFKTDLNG | 541 | Q8IZH2 | |
| PGASEGIKFYLYPDL | 276 | P48066 | |
| KDLYIDRPLPYLIGS | 176 | Q9Y4E1 | |
| ALAEGYRYPELDTPK | 31 | O95947 | |
| YRYPELDTPKLDCFL | 36 | O95947 | |
| ETSRRYPDLELKYGP | 71 | O75290 | |
| PLDPTIKYQYLREED | 491 | Q9NRE2 | |
| LPKIYAREGPDPYSV | 151 | Q9UFB7 | |
| LPAVFVYIEVKDYVP | 786 | Q9NQ66 | |
| YKYGQPIPRVEYTEE | 201 | Q8IWU9 | |
| PDSGEERLRYKYPSV | 66 | Q9UPN7 | |
| KDLYIDRPLPYLIGS | 176 | Q641Q2 | |
| PYVYAVGDILEDKPE | 471 | Q86VQ6 | |
| RFPIYKADLIPYQDS | 751 | Q8WUA4 | |
| YEEEPILKPGCKEYF | 1721 | Q70CQ2 | |
| RQPRKPFIIYEGDIY | 66 | Q9Y2P4 | |
| GPDYRLYKSEPELTT | 801 | Q9HAU0 | |
| EVVGKFYLDLYPREG | 406 | P52888 | |
| RGKLGLEEYAVFYPP | 346 | Q8N5T2 | |
| PEPLSSRYKLYEAEF | 11 | Q15849 | |
| YELDEKAVRPGYPKL | 181 | P04004 | |
| KFEPSTLYPYLREED | 526 | Q6ZSZ6 | |
| RPNGEKYDPDSILYL | 1296 | Q5VZL5 | |
| PISKYDEYGFLTVPD | 556 | Q9BYX2 | |
| EVKGPYEYLTLEDYP | 211 | Q8NBN3 | |
| DLRYKLSLEFPSGYP | 76 | O00762 | |
| SLPPEVAYFTYARDK | 516 | Q9HCX4 | |
| DRETLYPTFGKLYPE | 236 | Q8N8Y2 | |
| YKGRELYERPPHLFA | 66 | O94832 | |
| DPLTPGYPAKEYTFR | 256 | Q9Y3Q0 | |
| YVKTPEGLKPLDCFY | 416 | Q9Y2G1 | |
| SPDGSYRLPYKFEVQ | 716 | Q5VVJ2 |